THIS IS HUGE! They Proved They Can Silence mRNA That Produce Pathogenic Proteins | STOCK TO BUY

In the dynamic realm of finance, the stock market remains a focal point for investing and growing investments. As September approaches, investors are actively identifying stocks to buy, seeking the best high-growth opportunities that can withstand both a recession and inflation. While some keep an eye on stocks to watch, others delve into the realm of penny stocks. Navigating the market's intricacies, individuals are on the lookout for the best stocks to buy now, aiming to make informed choices that align with their strategies for this year's portfolio expansion.

Company Description
SLN Stock
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications.

The company's mRNAi GOLD GalNAc Oligonucleotide Discovery platform that is used to target specific disease-associated genes in the liver.

Its siRNA molecules to harness the body's natural mechanism of RNA interference, and degrading messenger RNA molecules that encode specific targeted disease-associated proteins in a cell.

The company develops SLN360, which is in phase 2 clinical development to reduce high levels of lipoprotein; SLN124 that is in Phase I clinical trials for the treatment of non-transfusion dependent thalassemia, and Phase I clinical trials for the treatment of myelodysplastic syndrome; and polycythemia vera.

Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Bull Market Watch as a whole. Bull Market Watch is not a licensed securities dealer, broker or US investment adviser or investment bank. My analysis is just for entertainment end/or educational purposes but may not be used as a basis to make an investment decision.

🔥 Disclaimer: Everything expressed in this video is a personal opinion provided for entertainment value only. I am not a professional nor a financial advisor. These are not instructions, suggestions, nor directions as to how to handle your money. Please, always do your own due diligence.